While the exact mechanisms are still unclear, ITM2B was identified as a downstream effector of miR-143 in GBM cells [67], which has a demonstrated role in GBM invasion [68]; the specific inhibition of miR-143 reduced GBM tumour growth and progression in vivo [67]. This evidence concerns the gene ITM2B and neoplasm.